LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer

NCT02328105 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Carboplatin
DRUG: Abraxane

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]